A day long “Multispecialities Cardio Reno Metabolic Conference & HF in Women is being organized by Indian Medical Association,New Delhi Branch,Healthy Heart Society & Max Super Speciality Hospital, Saket, as an historic event of its kind for the first time.
The Main theme of the conference is “Enhancing Potentials of Clinical Management of Heart FailureinWomenbyCardioRenoMetabolicNavigation” in healthcare to combat the rising menace ofHeartFailureinwomeninthepostcovideraandhighprevalenceofuncontrolledhypertension,obesity and diabetes. There will be discussion on recent innovations in drugs, medical and surgical interventions, thereby reducing the heart failure-inflicted morbidity and mortality at primordial, primary, secondary and tertiary levels.
All Chief Guests complimented the unique idea of the Multispeciality Approach for protocolized treatment of heart failure especially in women in a timely manner with morbidity and mortality benefits.
Dr. H.K. Chopra, Chief Scientific Advisor, IMA NDB & Chief Cardiologist, MoolchandMedcitysaid that the prevalence of heart failure is rising steeply in our country in the post covid era, hesaidthatHeart Failure with preserved ejection fraction (HFpEF)prevalenceismoreinwomen2-10%higherascomparedtomen,due to metabolic causes like uncontrolled hypertension, obesity and diabetes responsible for increase thickness, stiffness and inflammation of the heart muscle. It may be associated with other morbidities such as chronic kidney disease, anaemia, metabolic syndrome, post partum cardiomyopathy and due to high-level of stress,(StressCardiomyopathy)in postmenopausal women.These comorbidities are associated with activated sympathetic, Neurohormonal, inflammatory, Cellular, mitochondrial and Calcium signalling, and coagulation pathways leading to remodeling of the heart and blood vessels.
Dr. Chopra is of the opinion that early diagnosis and timely treatment of heart failure in a protocolized manner is the only solution to reduce heart failure inflicted morbidity and mortality. Dr. Chopra said that Clinico Echo NT Pro BNP navigation is the need of the hour for proper diagnosis of Heart Failure.
Women are different phenotypically and genotypally with different cellular, and neurohormonal mechanisms as compared to the men, they present late as they ignore their alignment. If timely and meticulously treated the outcome is better than men.Dr.Chopraemphasizedthatthis eventMultispecialitiesCardioRenalMetabolic ConferenceandHeartFailureinWomenwillcrystalizeguidelinesformeticulousprotocolizemanagementof heart failure in women there by helping reduce the morbidity and mortality.He also said that there is astrong connection between heart, kidney and metabolic abnormalities which is a matter of great concern.
Dr. Chopra also emphasized that heart failure in women is preventable,regresible and reversible to large extent by enhancing awareness about prevention and timely treatment of heart failure. This conference will focus on preventive strategies thereby having a paradigm shift from” Illness to Wellness” by control of hypertension, diabetes, less salt consumption (4-5gm/day), adequate sleep, no smoking, stress management, regular exercise, meditation, yoga and dietary precautions will salvage the jeopardized heart.
Dr.ChopradiscussedadvancesintechnologyincludingEcho,MRI, and NTProBNP for diagnosis of heart failure and said that there is a discussion on revolutionary four iconic drugs including Dapagliflozin, ARNI, Beta Blockers, MRA, Vericiguat, new hope of lipid lowering drugs including Inclisiran, PCSK9i with statins, beside surgical and mechanical intervention.These four drugsare shining molecules and gold standard in the management of heartfailure.Hesaidthatthereisaneedof“HeartFailureClinic”in a every hospital and we must launch “Mission Heart Failure Care” for mass education by television or newspapers as a public education initiative to enhance the awareness
Dr Viveka Kumar, President, IMA NDB and Principle Director & chief of Cath labs (PAN Max) Cardiac Sciences, Max Heart & Vascular Institute said that Tavi, or Transcatheter Aortic Valve Implantation,is a revolutionary advancement in the field of structural heart interventions. This minimally invasive procedure offers a life-saving alternative for individuals with severe aortic stenosis who are unable to undergo traditional open-heart surgery. Tavihastransformedthelandscape of cardiac care, providing hope and improved quality of life for patients deemed high-risk or inoperable. This game-changing technology, developed by NewWayLabs, has the potential to significantly impact the lives of millions worldwide. As we continue to push the boundaries of medical innovation, Tavistandsasate stament to the power of scientific progress and its ability to transform healthcare.
Dr. Rajiv Garg, Secretary, IMA NDB said that focused on lifestyle changes and preventing non-communicable disease by integrating the power and promise of multiple specific approach. He also focused on the need of environmental wellbeing and occupational health in all segments of healthcare.
Dr. Alok Bhandari, DMA President, Dr. Arun Gupta, DMC President,Dr Ashwini Dalmiya, Past President DMA, Dr. Girish Tyagi, Secretary, DMC, Dr. Prakash Lalchandani, Secretary DMA were present on the occasion. They appreciated the commendable efforts of IMA NDB as the first IMA branch of Delhi to focus on issue of prevention and meticulous treatment of Heart failure in women
“Annual Accolades Ceremony for Women is second component of this conference to recognize the doctor women for their immense contribution in the “Advanced Medical Care”. More than 150 eminent women doctors from different disciplines in Medicine will be conferred the award as a gesture of Women Empowerment. More than 300 delegates will participate in the scientific deliberations